Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial

Pentoxifylline (PTX) has broad-spectrum properties such as anti-inflammatory, anticoagulant, and antiviral effects. The aim of this study was to evaluate the efficacy and safety of PTX in hospitalized patients with COVID-19. This double-blind, placebo-controlled randomized clinical trial was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Hanieh, Rouhani, Nima, Shaki, Fatemeh, Karimpour-razkenari, Elahe, Ghazaeian, Monireh, Salehifar, Ebrahim, Saeedi, Majid, Fallah, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492603/
https://www.ncbi.nlm.nih.gov/pubmed/34666302
http://dx.doi.org/10.1016/j.intimp.2021.108227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492603/
https://www.ncbi.nlm.nih.gov/pubmed/34666302
http://dx.doi.org/10.1016/j.intimp.2021.108227

Ejemplares similares